M & As this week: Gilead Sciences, RegenxBio

Gilead Sciences and its subsidiary Dodgers Merger Sub plan to acquire Kite Pharma for $11.9bn.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news